Barriers to the use of hydroxyurea in the management of sickle cell disease in Nigeria. Adeyemo TA, Diaku-Akinwunmi IN, Ojewunmi OO, Bolarinwa AB, et al. Hemoglobin 2019;43:188-192.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Adeyemo TA, Diaku-Akinwunmi IN, Ojewunmi OO, Bolarinwa AB, et al. Barriers to the use of hydroxyurea in the management of sickle cell disease in Nigeria. Hemoglobin 2019;43:188-192.
PMID: 31462098